UBS Group’s GE HealthCare GEHC Stock Holding History

UBS Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$28.5K	Sell	400 -30,600	-99%	-$2.41M	﹤0.01%	7722
2025 Q4	$2.54M	Sell	31,000 -25,000	-45%	-$1.95M	﹤0.01%	4729
2025 Q3	$4.21M	Buy	56,000 +53,043	+1,794%	+$3.96M	﹤0.01%	4222
2025 Q2	$219K	Sell	2,957 -311,243	-99%	-$21.7M	﹤0.01%	6659
2025 Q1	$25.4M	Sell	314,200 -427,100	-58%	-$36.7M	﹤0.01%	2118
2024 Q4	$58M	Sell	741,300 -482,600	-39%	-$41M	0.01%	1327
2024 Q3	$115M	Buy	1,223,900 +922,400	+306%	+$77.4M	0.03%	658
2024 Q2	$23.5M	Buy	301,500 +300,000	+20,000%	+$24.5M	0.01%	1553
2024 Q1	$136K	Buy	+1,500	New	+$125K	﹤0.01%	6083

Other funds holding GEHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

UBS Group's GEHC Position: Q1 2026 in Review

UBS Group reduced its GE HealthCare (GEHC) stake by 1.5% in Q1 2026, selling an estimated $3.34M and leaving 2,805,315 shares worth $200M. The position accounts for 0.03% of the portfolio, ranked #616.

UBS Group first reported a position in GEHC in Q4 2022 and has held it in 14 quarters since. The position peaked at $309M in Q4 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

UBS Group held 2,805,315 shares of GE HealthCare worth $200M as of Q1 2026.
UBS Group sold 42,397 GE HealthCare shares in Q1 2026, an estimated $3.34M.
GE HealthCare made up 0.03% of UBS Group's portfolio in Q1 2026, its #616 holding.
UBS Group first reported a position in GE HealthCare in Q4 2022 and has held it in 14 quarters since.
UBS Group's GE HealthCare position peaked at $309M in Q4 2024.
1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.